LILRB1 and cancer: Nonetheless, because it can signal via similar pathways such as NKG2A and inhibitory KIRs25 and is expressed on 5–80% of NK cells,26 LIR‐1 remains of interest with respect to its potential role in NK cell education and immunotherapy of cancer.